Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile
about
Antifungal Therapy: New Advances in the Understanding and Treatment of MycosisProtective effect of a novel antifungal peptide derived from human chromogranin a on the immunity of mice infected with Candida krusei.A Chitin-binding Protein Purified from Moringa oleifera Seeds Presents Anticandidal Activity by Increasing Cell Membrane Permeability and Reactive Oxygen Species ProductionEvaluation of microbial load in oropharyngeal mucosa from tannery workers.Galleria mellonella model identifies highly virulent strains among all major molecular types of Cryptococcus gattiiCompetitive Interactions between C. albicans, C. glabrata and C. krusei during Biofilm Formation and Development of Experimental Candidiasis.A Madurella mycetomatis Grain Model in Galleria mellonella Larvae.Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations.Cryptococcus neoformans induces antimicrobial responses and behaves as a facultative intracellular pathogen in the non mammalian model Galleria mellonellaLactobacillus acidophilus ATCC 4356 inhibits biofilm formation by C. albicans and attenuates the experimental candidiasis in Galleria mellonella.Rapid development of Candida krusei echinocandin resistance during caspofungin therapy.Antiproliferative effect and characterization of a novel antifungal peptide derived from human Chromogranin A.Anti-candidal activity of a novel peptide derived from human chromogranin A and its mechanism of action against Candida kruseiCell Wall Changes in Amphotericin B-Resistant Strains from Candida tropicalis and Relationship with the Immune Responses Elicited by the HostComparison of virulence between Paracoccidioides brasiliensis and Paracoccidioides lutzii using Galleria mellonella as a host modelOptimization of the Expression Conditions of CGA-N46 in Bacillus subtilis DB1342(p-3N46) by Response Surface Methodology.Decreased expression of 14-3-3 in Paracoccidioides brasiliensis confirms its involvement in fungal pathogenesis.Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications.Understanding the Antifungal Mechanism of Ag@ZnO Core-shell Nanocomposites against Candida krusei.Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis virulence in the non-conventional host Galleria mellonella.Impact of Resistance to Fluconazole on Virulence and Morphological Aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates.Fluconazole Pharmacokinetics in Galleria mellonella Larvae and Performance Evaluation of a Bioassay Compared to Liquid Chromatography-Tandem Mass Spectrometry for Hemolymph Specimens.Virulence of Cryptococcus sp. Biofilms In Vitro and In Vivo using Galleria mellonella as an Alternative ModelUsefulness of the Non-conventional Caenorhabditis elegans Model to Assess Candida Virulence.Galleria mellonella as a model host for microbiological and toxin research.Galleria mellonella as a host model to study Aspergillus terreus virulence and amphotericin B resistance.The Synergistic Effect of Azoles and Fluoxetine against Resistant Candida albicans Strains Is Attributed to Attenuating Fungal Virulence.Antimicrobial activity of Aspilia latissima (Asteraceae)Galleria mellonella as a model host to study virulence of Candida.Synergistic Antifungal Effect of Fluconazole Combined with Licofelone against Resistant Candida albicans.Activity of gallic acid and its ester derivatives in Caenorhabditis elegans and zebrafish (Danio rerio) models.Galleria mellonella as a host model to study Candida glabrata virulence and antifungal efficacy.Of mice and men and larvae: Galleria mellonella to model the early host-pathogen interactions after fungal infection.A new and efficient method for the synthesis of novel 3-acetyl coumarins oxadiazoles derivatives with expected biological activity.From moths to caterpillars: Ideal conditions for Galleria mellonella rearing for in vivo microbiological studies.Photodynamic antimicrobial chemotherapy (PACT) using toluidine blue inhibits both growth and biofilm formation by Candida krusei.Experimental in Vivo Models of Candidiasis.CGA-N12, a peptide derived from chromogranin A, promotes apoptosis of Candida tropicalis by attenuating mitochondrial functions.Optimization of the expression conditions of CGA-N46 in Bacillus subtilis DB1342(p-3N46) by response surface methodology.Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.
P2860
Q28818603-E6EA1ED8-2027-48D3-83D2-6DACA4993491Q33724155-A9FD88EB-3C3A-4A49-89A1-DB49AE673426Q33766309-13E2B6CE-62CB-4227-A57E-3658A346F7CAQ35211480-52C975B3-F76A-4EAD-B1E9-1A9C6745ECDFQ35227221-18063FD3-7886-4DD6-8848-85696CD2CD12Q35683105-3217353B-AE3D-4BFF-8609-FFACB5C53CC7Q35691062-EB1E17E8-61D8-423D-94DA-18FACAAFDFE0Q36008037-7C88A4F5-E0BD-4089-BC0F-E2D0A720277BQ36154961-16C2EB58-7921-4F2F-A64A-891226B4F600Q36155002-BDE8A81F-2E63-4834-92B1-EB0B751353CCQ36158489-0BC482FF-E019-4775-B89B-CD91181A3D81Q36334389-D8A7D2BB-8228-4553-8F83-8A126C000DFFQ36335705-D6DE27B7-B10A-43AB-9F2B-C34D5AFB7EB8Q36729978-D88F044F-6FF8-4EFE-A5E5-48B95085D16FQ36782157-314B9E18-D344-4A86-AEA8-A197424D9EACQ37171208-75DBEEF3-71DA-4A9E-9FBE-E07D0B097E5FQ37197338-51654A7B-A7B7-4F55-8B9A-F87733997AD1Q37263791-3D690134-06E2-44F2-9E54-61C015F19D9CQ37393878-FCAF8835-F3E4-4CA9-B2CA-9CDB0E10A0B1Q38297389-DF7115EA-2434-42C9-813D-C53BDE9BDA26Q38467366-60DE7EA7-926D-4FCF-AD5C-D7BFDA1BB15FQ38649042-81B88F64-8543-414E-8D69-80455FB50ED3Q38858709-0338286D-7B52-457D-A9CE-FEFFBEF066D0Q40206406-4D0889C4-5407-4614-AF7B-2C19A5C38F59Q40630349-E86DB92E-6BBE-4BE8-8E37-A9E678994123Q40801674-D3D36497-EB29-4742-AB3F-C6C9FF711293Q41194566-6809827D-9031-4A03-9D39-2166BD3A5C7EQ42085381-46680B04-CCBD-4561-BC66-AE2B81F41038Q42408811-3A73AEDE-F5CB-4143-995C-1A3C3769499AQ47097867-AEE78E2E-5C47-41F2-A3F7-5B20D6A378A8Q47549081-42D1D453-51B7-4FC0-94ED-0943A75080BEQ48208159-80EB1E13-DD23-4D38-8975-C0DD3F22DDADQ48316319-0261EE19-5D10-4458-BDFA-2BE8FB1C16A9Q50003227-89C2FDE4-A2AD-42FE-BBAC-892B7B2B8992Q50052694-CFDBF475-6ED6-4877-911B-ED8E911D4C8CQ50053143-BB9886BF-00E4-4EE6-8C1A-1E74DB3E42ABQ50131894-E1232A41-7E5B-4CC1-8FC8-19218C736ADDQ52646178-66B4A32D-6D80-4291-BB65-B191C6371130Q53313332-F49C63F8-EA7D-40B7-B03C-61EBF6915E79Q55511181-5B77430F-3536-404A-A714-75A8A9C892AD
P2860
Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Antifungal efficacy during Can ...... n vitro susceptibility profile
@ast
Antifungal efficacy during Can ...... n vitro susceptibility profile
@en
Antifungal efficacy during Can ...... n vitro susceptibility profile
@nl
type
label
Antifungal efficacy during Can ...... n vitro susceptibility profile
@ast
Antifungal efficacy during Can ...... n vitro susceptibility profile
@en
Antifungal efficacy during Can ...... n vitro susceptibility profile
@nl
prefLabel
Antifungal efficacy during Can ...... n vitro susceptibility profile
@ast
Antifungal efficacy during Can ...... n vitro susceptibility profile
@en
Antifungal efficacy during Can ...... n vitro susceptibility profile
@nl
P2093
P2860
P50
P3181
P1433
P1476
Antifungal efficacy during Can ...... n vitro susceptibility profile
@en
P2093
Ana Cecilia Mesa-Arango
Ana Marisa Fusco-Almeida
Manuel Cuenca-Estrella
Maria Jose Mendes-Giannini
Maria Pilar de Lucas
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0060047
P407
P577
2013-01-01T00:00:00Z